American API Market is Expected to Grow at a Steady Rate in the Forecast Period

Friday 21 October 2011, Amsterdam

American API Market is Expected to Grow at a Steady Rate in the Forecast Period

The API market revenues in the Americas are expected to grow at a compound annual growth rate (CAGR) of 4.7% from 2010 to 2015. As the North American pharmaceutical market recovers from the impacts of economic downturn, API market revenues are expected to witness steady growth. The faster growing markets of South and Central America will provide a greater contribution to the overall growth of the API market in the Americas. Brazil in particular is witnessing very strong growth in pharmaceuticals and API market revenues and is expected to overtake Mexico in the coming years.

 
Branded Sector Currently Dominates the Americas Market while Maximum Growth is in Generic Sector

The American pharmaceutical and API market has been historically dominated by the branded sector. However, the growth pattern is rapidly changing. As a consequence of the impact of the global economic slowdown on some of the major American economies, the expenditure on research and innovation is controlled to some extent. Due to this, the growth of the branded sector of the API market has been impacted. On the other hand, the generic API sector is witnessing strong growth. This is mostly because of the patent expiries of some of the major branded drugs as well as healthcare cost containment measures. Generic sector APIs are expected to hold an increased share of the overall API market in the Americas by 2015.


The US Holds Largest Share of the Americas API Market Revenues while Brazil has Highest Growth Rate

As the US has been the world’s largest pharmaceutical market historically, it has a dominating share of the Americas’ API market revenues. Growth rates are expected to be higher in the markets of South and Central America than those in the North American market. Brazil is the fastest growing market in the region, and the country is expected to hold a significantly increased share of the Americas’ market revenue by 2015.



About this new market study:
This research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in the Americas. The report contains market forecasts, product type analysis, drivers and restraints, and details of the competitive landscape of major producers in the region. In addition, it includes market forecasts, product type analysis, therapeutic categories analysis and SWOT analysis of the API markets in the major countries of the region. Overall, the report presents a comprehensive analysis of the American API market, covering all the major parameters. The report is compiled using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.